Client login

API, Chemical Development & Analytical Services / Manufacturing Chemist Interview: Alistair Hay Head of Peptide Business and Process Development

Article

Back

Manufacturing Chemist Interview: Alistair Hay Head of Peptide Business and Process Development

From dark art to an age of enlightenment
Dr Kevin Robinson sits down with Almac Sciences’ Alistair Hay to discuss the recent happenings in Almac’s GMP peptides business, in terms of growth, development and strategic operations. They also discuss the company’s current focus on neoantigen-derived vaccines that harness the body’s own immune system to fight cancer.
Read the full article below

View Resource

Manufacturing Chemist Interview: Alistair Hay Head of Peptide Business and Process Development

Almac API, Chemical Development, Analytical & Solid State Services

Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).

We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.

Learn More

We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.

Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.

Learn More

You may also be interested in

Case study

Accurate determination of resin substitution in solid phase peptide synthesis

Almac Voice

Evaluation of the effects of residual carbon content matrix on the determination of pharmaceutically regulated elemental impurities by ICP-MS

Stay up-to-date with the latest from Almac

Join our mailing list

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies

Please complete this form to view the Article

Accurate determination of resin substitution in solid phase peptide synthesis

Evaluation of the effects of residual carbon content matrix on the determination of pharmaceutically regulated elemental impurities by ICP-MS